These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 3606330)

  • 21. The five-factor model of personality in borderline and nonborderline personality disorders.
    Zweig-Frank H; Paris J
    Can J Psychiatry; 1995 Nov; 40(9):523-6. PubMed ID: 8574987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The validity of DSM-III borderline personality disorder. A phenomenologic, family history, treatment response, and long-term follow-up study.
    Pope HG; Jonas JM; Hudson JI; Cohen BM; Gunderson JG
    Arch Gen Psychiatry; 1983 Jan; 40(1):23-30. PubMed ID: 6849616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topographic abnormalities of P3 in schizotypal personality disorder.
    Salisbury DF; Voglmaier MM; Seidman LJ; McCarley RW
    Biol Psychiatry; 1996 Aug; 40(3):165-72. PubMed ID: 8830949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Schizotypal personality disorder. Chestnut Lodge follow-up study: VI. Long-term follow-up perspectives.
    McGlashan TH
    Arch Gen Psychiatry; 1986 Apr; 43(4):329-34. PubMed ID: 3954556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eye tracking impairment in clinically identified patients with schizotypal personality disorder.
    Siever LJ; Keefe R; Bernstein DP; Coccaro EF; Klar HM; Zemishlany Z; Peterson AE; Davidson M; Mahon T; Horvath T
    Am J Psychiatry; 1990 Jun; 147(6):740-5. PubMed ID: 2343917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Personality disorders in a nonclinical sample of adolescents].
    Chabrol H; Chouicha K; Montovany A; Callahan S; Duconge E; Sztulman H
    Encephale; 2002; 28(6 Pt 1):520-4. PubMed ID: 12506264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Schizophrenia: reduced signal-to-noise ratio and impaired phase-locking during information processing.
    Winterer G; Ziller M; Dorn H; Frick K; Mulert C; Wuebben Y; Herrmann WM; Coppola R
    Clin Neurophysiol; 2000 May; 111(5):837-49. PubMed ID: 10802455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological markers in borderline personality disorder: new perspectives.
    Korzekwa M; Links P; Steiner M
    Can J Psychiatry; 1993 Feb; 38 Suppl 1():S11-5. PubMed ID: 8453532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Event-related potentials in adolescents with schizophrenia and their siblings: a comparison with attention-deficit/hyperactivity disorder.
    Groom MJ; Bates AT; Jackson GM; Calton TG; Liddle PF; Hollis C
    Biol Psychiatry; 2008 Apr; 63(8):784-92. PubMed ID: 17977520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P300 event-related potential abnormalities in borderline personality disorder.
    Blackwood DH; St Clair DM; Kutcher SP
    Biol Psychiatry; 1986 May; 21(5-6):560-4. PubMed ID: 3697445
    [No Abstract]   [Full Text] [Related]  

  • 31. Depression in borderline patients: a prospective EEG sleep study.
    Reynolds CF; Soloff PH; Kupfer DJ; Taska LS; Restifo K; Coble PA; McNamara ME
    Psychiatry Res; 1985 Jan; 14(1):1-15. PubMed ID: 3857645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinguishing bipolar II depression from major depressive disorder with comorbid borderline personality disorder: demographic, clinical, and family history differences.
    Zimmerman M; Martinez JH; Morgan TA; Young D; Chelminski I; Dalrymple K
    J Clin Psychiatry; 2013 Sep; 74(9):880-6. PubMed ID: 24107761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Borderline and schizotypal personality disorders: mutually exclusive or overlapping?
    Serban G; Conte HR; Plutchik R
    J Pers Assess; 1987; 51(1):15-22. PubMed ID: 3572708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Maudsley Family Study, II: Endogenous event-related potentials in familial schizophrenia.
    Frangou S; Sharma T; Alarcon G; Sigmudsson T; Takei N; Binnie C; Murray RM
    Schizophr Res; 1997 Jan; 23(1):45-53. PubMed ID: 9050127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The borderline syndromes of depression, mania and schizophrenia: the coaxial or temperamental approach.
    Bech P
    Acta Psychiatr Scand Suppl; 1994; 379():45-9. PubMed ID: 8010151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biological markers in schizotypal and borderline personality disorders].
    Ajamieh A; Ansseau M
    Encephale; 2000; 26(6):42-54. PubMed ID: 11217538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrophysiological correlates of language processing in schizotypal personality disorder.
    Niznikiewicz MA; Voglmaier M; Shenton ME; Seidman LJ; Dickey CC; Rhoads R; Teh E; McCarley RW
    Am J Psychiatry; 1999 Jul; 156(7):1052-8. PubMed ID: 10401451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Borderline personality disorder: symptomatology and MMPI characteristics.
    Resnick RJ; Schulz P; Schulz SC; Hamer RM; Friedel RO; Goldberg SC
    J Clin Psychiatry; 1983 Aug; 44(8):289-92. PubMed ID: 6874649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A critical examination of empirical studies of the diagnosis of borderline disorders in adults.
    Dahl AA
    Psychiatr Dev; 1985; 3(1):1-29. PubMed ID: 4001119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder.
    Cadenhead KS; Light GA; Geyer MA; Braff DL
    Am J Psychiatry; 2000 Jan; 157(1):55-9. PubMed ID: 10618013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.